StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International cash

Cash and short-term investments held at the end of each period.

Cryo-Cell International's cash was $4.23M at Aug 31, 2026. For fiscal 2025 it was $3.30M, down 5.7% from the year before. Over ten years it grew -3.6% a year on average. The highest annual figure on record is $10.45M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Nov 30, 2025$3.30M-5.7%
FY2024Nov 30, 2024$3.50M+256.7%
FY2023Nov 30, 2023$980.25K-43.1%
FY2022Nov 30, 2022$1.72M-79.4%
FY2021Nov 30, 2021$8.34M-20.2%
FY2020Nov 30, 2020$10.45M+40.4%
FY2019Nov 30, 2019$7.45M+7.7%
FY2018Nov 30, 2018$6.92M+2.9%
FY2017Nov 30, 2017$6.72M+62.9%
FY2016Nov 30, 2016$4.12M-13.4%
FY2015Nov 30, 2015$4.76M+40.8%
FY2014Nov 30, 2014$3.38M-14.7%
FY2013Nov 30, 2013$3.96M+48.0%
FY2012Nov 30, 2012$2.68M-63.4%
FY2011Nov 30, 2011$7.31M-23.1%
FY2010Nov 30, 2010$9.50M+38.7%
FY2009Nov 30, 2009$6.85M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026$4.23M+31.3%
Q2 FY2026CQ2 2026May 31, 2026$3.16M-28.6%
Q1 FY2026CQ1 2026Feb 28, 2026$2.90M-16.7%
Q4 FY2025CQ4 2025Nov 30, 2025$3.30M-5.7%
Q3 FY2025CQ3 2025Aug 31, 2025$3.22M+51.5%
Q2 FY2025CQ2 2025May 31, 2025$4.43M+189.7%
Q1 FY2025CQ1 2025Feb 28, 2025$3.48M+255.2%
Q4 FY2024CQ4 2024Nov 30, 2024$3.50M+256.7%
Q3 FY2024CQ3 2024Aug 31, 2024$2.13M+76.1%
Q2 FY2024CQ2 2024May 31, 2024$1.53M-9.6%
Q1 FY2024CQ1 2024Feb 29, 2024$979.59K-55.7%
Q4 FY2023CQ4 2023Nov 30, 2023$980.25K-43.1%
Q3 FY2023CQ3 2023Aug 31, 2023$1.21M-59.3%
Q2 FY2023CQ2 2023May 31, 2023$1.69M-41.0%
Q1 FY2023CQ1 2023Feb 28, 2023$2.21M-15.4%
Q4 FY2022CQ4 2022Nov 30, 2022$1.72M-79.4%
Q3 FY2022CQ3 2022Aug 31, 2022$2.96M-61.9%
Q2 FY2022CQ2 2022May 31, 2022$2.87M-64.3%
Q1 FY2022CQ1 2022Feb 28, 2022$2.62M-77.0%
Q4 FY2021CQ4 2021Nov 30, 2021$8.34M-20.2%
Q3 FY2021CQ3 2021Aug 31, 2021$7.77M-4.8%
Q2 FY2021CQ2 2021May 31, 2021$8.02M-14.0%
Q1 FY2021CQ1 2021Feb 28, 2021$11.36M+21.2%
Q4 FY2020CQ4 2020Nov 30, 2020$10.45M+40.4%
Q3 FY2020CQ3 2020Aug 31, 2020$8.17M-0.5%
Q2 FY2020CQ2 2020May 31, 2020$9.32M+27.6%
Q1 FY2020CQ1 2020Feb 29, 2020$9.37M+18.9%
Q4 FY2019CQ4 2019Nov 30, 2019$7.45M+7.7%
Q3 FY2019CQ3 2019Aug 31, 2019$8.21M+2.8%
Q2 FY2019CQ2 2019May 31, 2019$7.31M+2.7%
Q1 FY2019CQ1 2019Feb 28, 2019$7.88M+4.0%
Q4 FY2018CQ4 2018Nov 30, 2018$6.92M+2.9%
Q3 FY2018CQ3 2018Aug 31, 2018$7.99M+53.9%
Q2 FY2018CQ2 2018May 31, 2018$7.11M+37.4%
Q1 FY2018CQ1 2018Feb 28, 2018$7.58M+90.2%
Q4 FY2017CQ4 2017Nov 30, 2017$6.72M+62.9%
Q3 FY2017CQ3 2017Aug 31, 2017$5.19M–
Q2 FY2017CQ2 2017May 31, 2017$5.18M–
Q1 FY2017CQ1 2017Feb 28, 2017$3.98M–
Q4 FY2016CQ4 2016Nov 30, 2016$4.12M–

More Cryo-Cell International figures

See a number that looks wrong?